ACA(ACA)
ACA
Q4 2026 EPS Estimate
$1.56
Oct 29, 2026 · Reports after close
Revenue Estimate
$728M
FY2026E EPS$4.28
FY2027E EPS$4.87
Analyst Sentiment
Wall St. Consensus
Buy8 analysts·Limited coverage
72
Score
7 Buy (88%)1 Hold (13%)0 Sell (-1%)
Rating Breakdown
Strong Buy
00%
Buy
788%
Hold
113%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$140.00
-3.4%
Consensus
$145.00
+0.1%
Bull
$150.00
+3.5%
12-Month Target Range8 analysts
$140.00$145.00$150.00
Current $144.90Consensus
Current Price
$144.90
Upside to Consensus
$0.10
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+9.27%
EPS+13.73%
FY2028
Rev+2.67%
EPS+3.54%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.60B | $2.84B | $2.92B |
| Low | $2.59B | $2.76B | $2.88B |
| High | $2.61B | $2.92B | $2.97B |
| EBITDA Avg | $451M | $492M | $506M |
| Low | $449M | $479M | $499M |
| High | $452M | $506M | $515M |
| EBIT Avg | $262M | $287M | $294M |
| Low | $261M | $279M | $290M |
| High | $263M | $295M | $300M |
| Net Income Avg | $212M | $243M | $248M |
| Low | $206M | $230M | $242M |
| High | $215M | $246M | $253M |
| EPS Avg | $4.28 | $4.87 | $5.04 |
| Low | $4.20 | $4.70 | $4.95 |
| High | $4.38 | $5.03 | $5.16 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 3 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $728M | $644M | $610M | $722M | $766M | $681M |
| Low | $725M | $640M | $607M | $719M | $762M | $678M |
| High | $731M | $648M | $613M | $726M | $770M | $685M |
| EBITDA Avg | $126M | $112M | $106M | $125M | $133M | $118M |
| Low | $126M | $111M | $105M | $124M | $132M | $117M |
| High | $127M | $112M | $106M | $126M | $133M | $119M |
| EBIT Avg | $73M | $65M | $61M | $73M | $77M | $69M |
| Low | $73M | $65M | $61M | $72M | $77M | $68M |
| High | $74M | $65M | $62M | $73M | $78M | $69M |
| Net Income Avg | $76M | $50M | $30M | $69M | $85M | $54M |
| Low | $75M | $48M | $30M | $68M | $85M | $53M |
| High | $78M | $51M | $30M | $69M | $86M | $54M |
| EPS Avg | $1.55 | $1.01 | $0.61 | $1.40 | $1.73 | $1.09 |
| Low | $1.52 | $0.98 | $0.61 | $1.39 | $1.72 | $1.08 |
| High | $1.58 | $1.04 | $0.61 | $1.41 | $1.74 | $1.10 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |